|Targets||5-HT Receptor | Dopamine Receptor|
|Description||Sarizotan, also known as EMD-128130, is a full 5-HT1a agonist and a dopamine D2-like agonist/partial agonist used in clinical trials for the treatment of l-dopa-induced dyskinesia.|
|Related CAS||177976-12-4 (Sarizotan 2 HCl salt); 195068-07-6 (Sarizotan HCl salt); 351862-32-3 (Sarizotan free base)|
|Synonyms||1-[(2R)-3,4-dihydro-2H-chromen-2-yl]-N-[[5-(4-fluorophenyl)pyridin-3-yl]methyl]methanamine;hydrochloride; EMD128130; sarizotan; 177976-12-4 (Sarizotan 2 HCl salt); 351862-32-3 (Sarizotan free base); sarizotan hydrochloride|
NAS-181 is a 5-HT1B receptor antagonist with Ki value of 47 nM. It can increase synthesis and metabolism of 5-HT in the brain following systemic administration ...
The hydrochloride salt form of Adrogolide,a quinoline derivative, has been found to be a dopamine D1 receptor agonist that was once studied in Parkinson's disea...
NPEC-caged serotonin is a caged version of serotonin.
A dopamine receptor agonist.
Agomelatine is a melatoninergic agonist and selective antagonist of 5-HT2C receptors, and has been shown to be active in several animal models of depression. Ag...
PNU 177864 hydrochloride
PNU 177864, a trifluromethoxy-phenylsulphonylamine, is a highly selective dopamine D3 receptor antagonist, which induces phospholipidosis and exhibits antischiz...
Raclopride, also known as FLA 870, is a selective and potent dopamine D2/D3 receptor antagonist. It has high affinity (Kd = 1.2 nM) and high selectivity for D2 ...
R(-)-Norapomorphine hydrobromide is a potent dopamine receptor agonist.